by Bruce Sylvester: Treatment with the growth hormone growth factor-1 (IGF-1) significantly improves social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome,… read more.
National Institutes of Health-supported study examines prescribing patterns. Prescription use of benzodiazepines, increases steadily with age, despite the known risks for older people, according to a comprehensive analysis… read more.
E-cigarettes appear to be less addictive than cigarettes for former smokers and this could help improve understanding of how various nicotine delivery devices lead to dependence, according to… read more.
Computers scientists, who have already used Twitter posts to track flu cases, say their techniques also show promise as a tool to gather important information about some common… read more.
Substance abuse assessments needed before drugs are prescribed, researchers say. Teens prescribed anti-anxiety or sleep medications may be up to 12 times more likely to abuse those drugs… read more.
Controlling pain during childbirth and post delivery may reduce the risk of postpartum depression, writes Katherine Wisner, M.D., perinatal psychiatrist, in an editorial in Anesthesia & Analgesia.
Controlling childbirth pain appears to lower the risk of postpartum depression, researchers reported in a July 23 editorial in Anesthesia & Analgesia.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
Emerging uses of FDA approved drugs – by Bruce Sylvester – Over half of depressed subjects in a newly reported study who were injected with onabotulinumtoxinA (OBA/Botox) achieved… read more.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
